Abstract
To evaluate the usefulness of the Glasgow Prognostic Score (GPS) in patients with esophageal carcinoma (EC). A total of 50 patients with EC were analyzed for GPS, nutritional and clinicopathologic parameters. Patients with CRP ≤ 1.0mg/L and albumin ≥ 3.5mg/L were considered as GPS = 0. Patients with only CRP increased or albumin decreased were classified as GPS = 1 and patients with CRP > 1.0mg/L and albumin < 3.5mg/L were considered as GPS = 2. GPS of 0, 1 and 2 were observed in seven, 23 and 20 patients, respectively. A significant inverse relationship was observed between GPS scores and the survival rate. The survival rate was greatest in patients with GPS = 0 and significantly higher than those from patients with GPS = 1 and GPS = 2. Minimum 12-month survival was observed in 71% patients with GPS = 0 and in 30% patients with GPS = 1. None of the patients with GPS = 2 survived for 12 months. A significant relationship between CRP or albumin individually and the survival rate was observed. No significant relationship among nutritional, clinic pathological parameters and survival was found. Glasgow Prognostic Score is an useful tool to predict survival in patients with esophageal carcinoma.
References
Jan 1, 1977·JPEN. Journal of Parenteral and Enteral Nutrition·G L BlackburnM F Smith
Feb 1, 1982·The American Journal of Clinical Nutrition·C E Cronk, A F Roche
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H J AndreyevD Cunningham
Jul 21, 2000·Annals of Surgery·N AndoM Kitajima
Aug 31, 2000·Nutrition and Cancer·P O'GormanC S McArdle
Jan 5, 2002·Nutrition and Cancer·D C McMillanC S McArdle
Sep 19, 2002·Cancer·Mohamad A EloubeidiC Mel Wilcox
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Dec 4, 2003·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·S NatsugoeUNKNOWN Kyushu Study Group for Adjuvant Therapy of Esophageal Cancer
Dec 6, 2003·The New England Journal of Medicine·Peter C Enzinger, Robert J Mayer
Jul 28, 2005·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·P Guillem, J P Triboulet
Feb 16, 2006·British Journal of Cancer·A B C CrumleyR C Stuart
May 3, 2008·The Proceedings of the Nutrition Society·Donald C McMillan
Feb 7, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Chang-Yu WangYu-Jie Huang
Mar 26, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Donald C McMillan
Oct 29, 2010·Annals of Surgical Oncology·Yogesh K VashistJakob R Izbicki
Nov 17, 2010·Revista do Colégio Brasileiro de Cirurgiões·Emerson Luis Gama PriscoEduardo Linhares Riello de Mello
Jan 6, 2012·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Jingeng LiuJianhua Fu
Sep 22, 2012·Cancer Treatment Reviews·Donald C McMillan
Feb 2, 2013·Nutrition and Cancer·Jacqueline Braga da SilvaMaria Isabel T D Correia